PAVmed Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Revenue	2.45	0.38	0.5	0	0	Upgrade
Revenue Growth (YoY)	550.40%	-24.60%	-	-	-	Upgrade
Cost of Revenue	6.42	3.61	0.59	0	0	Upgrade
Gross Profit	-3.97	-3.24	-0.09	0	0	Upgrade
Selling, General & Admin	48.53	60.73	34.32	12.39	7.67	Upgrade
Research & Development	14.28	25.34	19.85	10.96	6.63	Upgrade
Other Operating Expenses	2.02	1.78	0.15	0	0	Upgrade
Operating Expenses	64.83	87.85	54.31	23.35	14.3	Upgrade
Operating Income	-68.8	-91.09	-54.39	-23.35	-14.3	Upgrade
Interest Expense / Income	0.59	1.28	0	0.05	0.03	Upgrade
Other Expense / Income	-5.21	-3.39	-4.05	10.87	2.13	Upgrade
Pretax Income	-64.18	-88.98	-50.35	-34.28	-16.46	Upgrade
Net Income	-64.18	-88.98	-50.35	-34.28	-16.46	Upgrade
Preferred Dividends	2.1	0.28	0.28	0.29	0.27	Upgrade
Net Income Common	-66.27	-89.26	-50.63	-34.56	-16.73	Upgrade
Shares Outstanding (Basic)	7	6	5	3	2	Upgrade
Shares Outstanding (Diluted)	7	6	5	3	2	Upgrade
Shares Change	21.78%	14.91%	63.42%	57.07%	35.56%	Upgrade
EPS (Basic)	-9.16	-15.03	-9.75	-10.80	-8.10	Upgrade
EPS (Diluted)	-9.16	-15.03	-9.75	-10.80	-8.10	Upgrade
Free Cash Flow	-51.28	-72.53	-42.06	-21.97	-13.38	Upgrade
Free Cash Flow Per Share	-7.09	-12.21	-8.14	-6.95	-6.65	Upgrade
Gross Margin	-161.83%	-858.62%	-17.00%	-	-	Upgrade
Operating Margin	-2805.67%	-24161.01%	-10878.60%	-	-	Upgrade
Profit Margin	-2702.69%	-23677.45%	-10126.00%	-	-	Upgrade
Free Cash Flow Margin	-2091.27%	-19237.40%	-8412.00%	-	-	Upgrade
EBITDA	-60.35	-85.15	-50.12	-34.2	-16.41	Upgrade
EBITDA Margin	-2461.09%	-22585.68%	-10024.20%	-	-	Upgrade
Depreciation & Amortization	3.24	2.55	0.23	0.02	0.01	Upgrade
EBIT	-63.59	-87.7	-50.35	-34.22	-16.42	Upgrade
EBIT Margin	-2593.23%	-23263.13%	-10069.40%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).